← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

Director Michael Douglas Taylor sold $1.3M of Deciphera Pharmaceuticals, Inc.

Sold$1,343,926
$57.64Price
23,315Shares
−100%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Mon, Nov 2. Filed Wed, Nov 4, 11:10 AM ET, during the session. Not investment advice.